Comparison of the Effect of Gluten-Free-Lactose-Free / Aronia Melanocarpa Supplemented Diet in Patients With Hashimoto's Thyroiditis

NCT ID: NCT06419309

Last Updated: 2024-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-05-15

Study Completion Date

2025-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hashimoto's thyroiditis (HT) is the most common cause of chronic hypothyroidism in areas with sufficient iodine, stemming from an autoimmune response against thyroid peroxidase and/or thyroglobulin. It is the most prevalent autoimmune thyroid disease and a leading cause of overall hypothyroidism. Even when they reach euthyroidism, 82% of treated women with HT still have excess body weight, and 35% of them are obese. Thyroid dysfunction can affect the function of adipose tissue and lead to metabolic disturbances. Leptin can stimulate thyroid-stimulating hormone secretion, while thyroid-stimulating hormone can influence leptin release from adipose tissue. Additionally, HT patients often exhibit high levels of C-reactive protein and interleukin-6, suggesting an association between increased thyroid-stimulating hormone levels and the inflammatory process, which may contribute to comorbid disease risk in individuals with HT. Nutrition can serve as a complementary treatment for HT by affecting thyroid functions and having anti-inflammatory properties. Dietary interventions may involve eliminating gluten, lactose, or certain food components, or focusing on an anti-inflammatory dietary pattern while preventing nutritional deficiencies. Therefore, this study is a randomized controlled, single-blind trial designed to evaluate the effects of a gluten-free, lactose-free diet and a diet enriched with Aronia Melanocarpa, both individually and in combination, as well as healthy dietary protocols, on autoantibody levels, leptin, ghrelin, oxidative response, and weight loss in patients with Hashimoto's thyroiditis. The study aims to recruit a minimum of 80 participants aged 18-65 years, diagnosed with Hashimoto's thyroiditis at Istanbul Medical Faculty Hospital. In the initial face-to-face interview, participants will provide sociodemographic information, dietary habits, anthropometric measurements, and dietary intake records through a questionnaire. The study involves the inclusion of Aronia Melanocarpa in the diet (high anthocyanin content, 69.24 mg/100 ml), a gluten-free and lactose-free diet, both interventions being applied together, and the application of only healthy nutrition protocols to patients over an 8-week period, with serum assessments of thyroid-stimulating hormon, free T4, free T3, anti-thyroid peroxidase, anti-Tg, interleukin-6,anti tumor necrosis factor alpha, C-reactive protein and leptin-ghrelin levels at the beginning and end of the study. The goal is to create recommendations for patients, improve their quality of life, and establish sustainable nutritional interventions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hashimoto Thyroiditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gluten- lactose free diet

People will be given a healthy diet by eliminating gluten-free lactose-containing foods from their diet. It will continue for 8 weeks.

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

Four different dietary interventions are planned.

* Gluten-free, lactose-free diet,
* Diet enriched with Aronia Melanocarpa,
* Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet,
* Healthy diet

Aronia Melanocarpa added and Gluten- lactose free diet

In addition to a healthy diet, people will be given aronia melanocarpa fruit juice daily (high in anthocyanins, 69.24 mg/100 mL cyanidin-3-glucoside) and a gluten-free-lactose-free diet.It will continue for 8 weeks.

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

Four different dietary interventions are planned.

* Gluten-free, lactose-free diet,
* Diet enriched with Aronia Melanocarpa,
* Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet,
* Healthy diet

Aronia Melanocarpa added diet

People will be given aronia melanocarpa fruit juice daily (high in anthocyanins, 69.24 mg/100 mL cyanidin-3-glucoside).It will continue for 8 weeks.

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

Four different dietary interventions are planned.

* Gluten-free, lactose-free diet,
* Diet enriched with Aronia Melanocarpa,
* Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet,
* Healthy diet

Healthy eating group

Healthy diet patterns with an average macronutrient content of 10-20% protein, 20-35% fat and 45-60% carbohydrate will be followed for 8 weeks.

Group Type EXPERIMENTAL

Dietary intervention

Intervention Type OTHER

Four different dietary interventions are planned.

* Gluten-free, lactose-free diet,
* Diet enriched with Aronia Melanocarpa,
* Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet,
* Healthy diet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary intervention

Four different dietary interventions are planned.

* Gluten-free, lactose-free diet,
* Diet enriched with Aronia Melanocarpa,
* Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet,
* Healthy diet

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being diagnosed with Hashimoto's thyroiditis by a doctor,
* Being a female individual between the ages of 18-65,
* Not being diagnosed with any chronic disease that would negatively affect functioning other than Hashimoto's thyroid,
* Not having used selenium and iodine supplements in the last month,
* Individuals should not lose more than 4 kg of weight in the last month,
* Not having been on a strict elimination diet for more than 4 months in the last year,
* Not having applied any nutritional intervention during the last three months before the study.

Exclusion Criteria

* Pregnant or breastfeeding mother,
* Individuals with chronic diseases,
* Individuals allergic to red fruits
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Halic University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Berrak Basturk, Lecturer

Role: PRINCIPAL_INVESTIGATOR

Halic University

Zeynep Ozerson, Assoc. prof.

Role: STUDY_DIRECTOR

Halic University

Ayse Kubat Uzum, Profesor

Role: STUDY_DIRECTOR

Istanbul University

Melike Cevikdizici, Nurse

Role: STUDY_DIRECTOR

Istanbul University

Yusuf Celik, Profesor

Role: STUDY_DIRECTOR

Biruni University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Halic University

Istanbul, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Berrak Basturk, Lecturer

Role: CONTACT

05465088090

Ayse Kubat Uzum, Profesor

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Berrak Basturk, Lecturer

Role: primary

+905465088090

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUSBFBVDBE001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.